An optimized protocol for the retroviral transduction of mouse CD4 T cells

Summary: Transduction of primary T cells has become prominent with the introduction of chimeric antigen receptor T-cell therapy. Although there are many protocols for the transduction of human T cells, it remains a challenge to transduce murine T cells. We present an optimized protocol for the retro...

Full description

Bibliographic Details
Main Authors: Ekaterina Eremenko, Zoe V. Taylor, Bishnu Khand, Shir Zaccai, Angel Porgador, Alon Monsonego
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166721004263
id doaj-c64dd8db782a4cf282175d61248356e4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ekaterina Eremenko
Zoe V. Taylor
Bishnu Khand
Shir Zaccai
Angel Porgador
Alon Monsonego
spellingShingle Ekaterina Eremenko
Zoe V. Taylor
Bishnu Khand
Shir Zaccai
Angel Porgador
Alon Monsonego
An optimized protocol for the retroviral transduction of mouse CD4 T cells
STAR Protocols
Cell culture
Cell-based Assays
Cell separation/fractionation
Immunology
Molecular Biology
author_facet Ekaterina Eremenko
Zoe V. Taylor
Bishnu Khand
Shir Zaccai
Angel Porgador
Alon Monsonego
author_sort Ekaterina Eremenko
title An optimized protocol for the retroviral transduction of mouse CD4 T cells
title_short An optimized protocol for the retroviral transduction of mouse CD4 T cells
title_full An optimized protocol for the retroviral transduction of mouse CD4 T cells
title_fullStr An optimized protocol for the retroviral transduction of mouse CD4 T cells
title_full_unstemmed An optimized protocol for the retroviral transduction of mouse CD4 T cells
title_sort optimized protocol for the retroviral transduction of mouse cd4 t cells
publisher Elsevier
series STAR Protocols
issn 2666-1667
publishDate 2021-09-01
description Summary: Transduction of primary T cells has become prominent with the introduction of chimeric antigen receptor T-cell therapy. Although there are many protocols for the transduction of human T cells, it remains a challenge to transduce murine T cells. We present an optimized protocol for the retroviral transduction of murine CD4 T cells, which overcomes major challenges including large-scale production and long-term culturing of transduced cells. The optimized protocol combines high transduction efficiency with a low rate of cell death.For complete details on the use and execution of this protocol, please refer to Eremenko et al., 2019.
topic Cell culture
Cell-based Assays
Cell separation/fractionation
Immunology
Molecular Biology
url http://www.sciencedirect.com/science/article/pii/S2666166721004263
work_keys_str_mv AT ekaterinaeremenko anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT zoevtaylor anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT bishnukhand anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT shirzaccai anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT angelporgador anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT alonmonsonego anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT ekaterinaeremenko optimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT zoevtaylor optimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT bishnukhand optimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT shirzaccai optimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT angelporgador optimizedprotocolfortheretroviraltransductionofmousecd4tcells
AT alonmonsonego optimizedprotocolfortheretroviraltransductionofmousecd4tcells
_version_ 1717376159208964096
spelling doaj-c64dd8db782a4cf282175d61248356e42021-09-19T05:00:45ZengElsevierSTAR Protocols2666-16672021-09-0123100719An optimized protocol for the retroviral transduction of mouse CD4 T cellsEkaterina Eremenko0Zoe V. Taylor1Bishnu Khand2Shir Zaccai3Angel Porgador4Alon Monsonego5The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; Corresponding authorThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, IsraelThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, IsraelThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, IsraelThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; Corresponding authorThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; Corresponding authorSummary: Transduction of primary T cells has become prominent with the introduction of chimeric antigen receptor T-cell therapy. Although there are many protocols for the transduction of human T cells, it remains a challenge to transduce murine T cells. We present an optimized protocol for the retroviral transduction of murine CD4 T cells, which overcomes major challenges including large-scale production and long-term culturing of transduced cells. The optimized protocol combines high transduction efficiency with a low rate of cell death.For complete details on the use and execution of this protocol, please refer to Eremenko et al., 2019.http://www.sciencedirect.com/science/article/pii/S2666166721004263Cell cultureCell-based AssaysCell separation/fractionationImmunologyMolecular Biology